reports
- ABGSC Pulp & Paper Research
- Henrik Bartnes
- Martin Melbye
- ABGSC Pulp & Paper Research
- Henrik Bartnes
- Martin Melbye
- ABGSC Pulp & Paper Research
- Henrik Bartnes
- Martin Melbye
- ABGSC Oil & Oil Services Research
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
EQNR EQUINOR ASA
AKAST AKASTOR ASA
KOG KONGSBERG GRUPPEN ASA
SOC SUBSEA 7 S.A.
PEN PANORO ENERGY ASA
ARCHERO ARCHER
AKER AKER ASA CLASS A
DNO DNO ASA CLASS A
TGS TGS-NOPEC GEOPHYSICAL COMPANY ASA
ODL ODFJELL DRILLING
AKSOO AKER SOLUTIONS ASA
BWO BW OFFSHORE LIMITED
PRS PROSAFE
OKEA OKEA
BWE BW ENERGY
VAR VAR ENERGI ASA
SEAPT-NO SEACREST PETROLEO
DOFG DOF GROUP ASA
Borregaard ASA: Issuance of Commercial Paper
Borregaard ASA: Issuance of Commercial Paper Borregaard ASA has issued a commercial paper ISIN NO0013597476 of NOK 100,000,000. Start date: 19 June, 2025Maturity: 19 September, 2025Coupon: 4.78 %Organised by: DNB CarnegieSarpsborg, 17 June 2025 Contact:Director Investor Relations, Knut-Harald Bakke, This information is subject to the disclosure requirements pursuant to Section 5 -12 of the Norwegian Securities Trading Act.
- ABGSC Capital Goods Research
- Simon Brun
Borregaard ASA: Change in Group Executive Management
Borregaard ASA: Change in Group Executive Management Knut-Harald Bakke has been appointed EVP BioSolutions, effective 1 August 2025. He will also join the Group Executive Management on the same date. Bakke succeeds Tom Erik Foss-Jacobsen, who will assume the role of CEO on 1 August (see stock exchange release dated 23 May 2025). Bakke currently serves as Director of Investor Relations and has previously held the position of Energy Director at Borregaard. Prior to joining the company in 2019, he held senior leadership roles at Norsk Hydro, where he was responsible for global energy market o...
Borregaard ASA: 2 directors
Two Directors at Borregaard ASA bought 4,000 shares at between 187.920NOK and 188.040NOK. The significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over th...
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares m...
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities John Arne Ulvan, member of the board of Borregaard ASA, has on 27 May 2025 purchased 2,000 shares in Borregaard ASA at a price of NOK 188.04 per share. Following this transaction, John Arne Ulvan owns 5,500 shares in Borregaard ASA. The shares are purchased at Oslo Stock Exchange. Shareholder-elected board members shall use 20% of their gross remuneration to purchase shares in the company until they own shares equal in value to one year’s gross board remuneration. The...
- ABGSC Pulp & Paper Research
- Henrik Bartnes
- Martin Melbye
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares m...
Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities Tove Andersen, member of the board of Borregaard ASA, has on 27 May 2025 purchased 2,000 shares in Borregaard ASA at a price of NOK 187.92 per share. Following this transaction, Tove Andersen owns 11,100 shares in Borregaard ASA together with related parties. The shares are purchased at Oslo Stock Exchange. Shareholder-elected board members shall use 20% of their gross remuneration to purchase shares in the company until they own shares equal in value to one year’s gr...
- ABGSC Energy Research
- Daniel Vårdal Haugland
- John Olaisen
- Njål Kleiven
- Oliver Dunvold
- Stian Wibstad
Borregaard ASA: Tom Erik Foss-Jacobsen appointed CEO of Borregaard
Borregaard ASA: Tom Erik Foss-Jacobsen appointed CEO of Borregaard Tom Erik Foss-Jacobsen has been appointed CEO of Borregaard ASA. He succeeds Per A. Sørlie, who will retire after 26 years in the position (see notice to Oslo Stock Exchange 3 December 2020). The appointment will be effective 1 August 2025. “I am pleased that Tom Erik Foss-Jacobsen has accepted the position as CEO of Borregaard. With Foss-Jacobsen, Borregaard will get a leader with in-depth understanding of the business and previous experience from significant parts of Borregaard’s international operations. Over several yea...
- ABGSC Pulp & Paper Research
- Henrik Bartnes
- Martin Melbye
SCA B SVENSKA CELLULOSA AKTIEBOLAGET CLASS B
STERV STORA ENSO OYJ CLASS R
HUH1V HUHTAMAKI OYJ
RROS ROTTNEROS AB
METSB METSA BOARD OYJ CLASS B
BILL BILLERUDKORSNAS AB
ATC ARCTIC PAPER SA
BRG BORREGAARD
HOLM B HOLMEN AB CLASS B
NPAPER NORDIC PAPER HOLDING
ELO ELOPAK ASA
BRG.B-SE BERGS TIMBER
NSKOG NORSKE SKOG ASA
- ABGSC Pulp & Paper Research
- Henrik Bartnes
- Martin Melbye
- ABGSC Services Research
- Stefan Knutsson
Novo Nordisk AS: 1 director
A director at Novo Nordisk AS sold 40,000 shares at 450.528DKK and the significance rating of the trade was 100/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clear...
- Rune Majlund Dahl
Zealand Pharma (Buy, TP: DKK950.00) - Dapiglutide likely next catalyst
Q1 revenue missed expectations on lower reimbursement revenue, while operating profit was a beat, as opex was below our forecast and consensus. The 2025 guidance was maintained for opex of DKK2,000m–2,500m. We believe the next potential share-price catalyst is the top-line results from the phase Ib dapiglutide trial in Q2e. We reiterate our BUY, but have cut our target price to DKK950 (1,000).
- Niclas Gehin
Kongsberg Gruppen (Sell, TP: NOK1250.00) - Expectations are set too hi...
We have downgraded Kongsberg Gruppen to SELL (HOLD) and lowered our target price to NOK1,250 (1,450). We believe the 2025e P/E of 46x overstates its growth capabilities 1) on an absolute basis, in a scenario where all of NATO reaches defence spending of 3.3% of GDP; and 2) compared to other defence companies as, in our view, the market appears to miss that only 20% of its 2024 sales were from European defence spending.
- ABGSC Services Research
- Stefan Knutsson
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.